Mayuri Bharathan
Medical · Berkley, MINPI 1487395455
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,145 of the $7,844 with a category attached, or 78.3%. 10 manufacturers reported payments, led by Gilead at 57.1% of the total. Reporting peaked in 2023 at $3,387 and has fallen 69.2% since, to $1,042 in 2025. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 222 payments — averaging $35.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- Viiv Healthcare Company$2K
- Merck$392
- Braeburn Inc.$197
- Indivior Inc.$139
- AbbVie$118
- plus $118 from 4 others
What the payments were for
- Consulting fees$1,57020%
- Travel & lodging$1292%
- Food & beverage$6,14578%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 95 | $4,482 |
| Viiv Healthcare Company | 94 | $2,398 |
| Merck | 9 | $392 |
| Braeburn Inc. | 7 | $197 |
| Indivior Inc. | 6 | $139 |
| AbbVie | 5 | $118 |
| Alkermes, Inc. | 3 | $63 |
| Novo Nordisk | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Orexo US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,844 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 36 | $148,123 |
| DovatoDolutegravir Sodium/Lamivudine | 24 | $66,284 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 92 | $19,084 |
| LinzessLinaclotide | 12 | $6,074 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $4,303 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $1,010 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $778 |
| Gabapentin | 72 | $489 |
| Quetiapine Fumarate | 34 | $466 |
| Tamsulosin Hcl | 23 | $433 |
| Bupropion XlBupropion Hcl | 12 | $342 |
| Cyclobenzaprine Hcl | 30 | $272 |
| Omeprazole | 30 | $234 |
| Atorvastatin Calcium | 37 | $228 |
| Hydroxyzine Pamoate | 12 | $211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $4,482 | $148,12336 claims |
| Viiv Healthcare CompanyDovato | $2,398 | $66,28424 claims |
| AbbVieLinzess | $118 | $6,07412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 755 medical providers in Michigan.
Other medical in Berkley
- Caleb YoungbloodBerkley$215K
- Mark RosenBerkley$32K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$56K
- David WilkinsMuskegon$41K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.